Phase 2 Study of ABT-510 in Patients with Previously Untreated Advanced Renal Cell CarcinomaScot Ebbinghaus, Robert A. Figlin, Apurva A. Desai et al.|Clinical Cancer Research|2007Cited by 89
A randomized phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with previously untreated advanced renal cell carcinomaScot Ebbinghaus, Robert A. Figlin, M Hussain et al.|Journal of Clinical Oncology|2005Cited by 9